Home › Business › Pharmaceuticals News

Latest Stories

Pfizer closing Irish plant

 May 18, 2013

Pfizer Inc. has announced the closure of an Irish production plant that will lead to 136 job cuts.

The New York-based drug giant said the closure of its Little Island manufacturing plant in Cork was the result of "changing global demand"...

Feds offer more benefits to 390 laid-off Pfizer workers

 May 17, 2013

Nearly 400 former workers at Pfizer Inc., including some who were working at the Groton laboratories as contractors for ExecuPharm Inc., have been told they qualify for federal benefits after their jobs were moved overseas.

The U.S.

Quarterly sends Amarin stock soaring

 May 11, 2013

Dublin-based biotech Amarin Corp. plc's stock took a ride upward Friday, one day after releasing first-quarter financial results that gave an early glimpse of how sales of its newly approved heart medication, Vascepa, are proceeding.

Drugs falling out of patent mean savings

 May 10, 2013

As more top-selling drugs went off patent in 2012, Americans for the first time in decades spent less money on medicines than they had the previous year.
The New York-based IMS Institute for Healthcare...

Pfizer R&D webcast today

 May 10, 2013

Pfizer Inc. is inviting investors and the public to attend a webcast at 11 a.m. today in which Mikael Dolsten, president of its research-and-development division worldwide, speaks during the Morgan Stanley 2013 R&D Seminar called Reigniting...

Amarin managers to discuss finances

 May 8, 2013

Senior managers of Amarin Corp. plc, a biotech company with research headquarters in Groton, will discuss the company's first-quarter financial results at 4:30 p.m. Thursday during a conference call.

To participate in the call, dial...

Pfizer's first-quarter revenues disappoint

 May 1, 2013

New drugs spurred along by research at Pfizer Inc. laboratories in Groton couldn't provide enough lift to make up for losses in the company's established portfolio as the firm announced disappointing first-quarter financial results...

Pfizer and Merck partner to develop diabetes drug

 April 30, 2013

Drug giant Pfizer Inc. has joined forces with competitor Merck & Co. Inc. to co-develop a new medicine for patients with type 2 diabetes, the companies announced Monday.

Pfizer, which has a research-and-development site in Groton, currently...

Pfizer’s first-quarter results disappoint Wall Street

 April 30, 2013

Pfizer Inc. reported disappointing first-quarter financial results this morning, with dramatically increased profits failing to mask weaknesses in pharmaceutical sales.

Pfizer declares 24-cent dividend

 April 27, 2013

The board of directors of Pfizer Inc. declared Thursday a 24-cent second-quarter 2013 dividend on the company's common stock, payable June 4 to shareholders of record at the close of business on May 10.

Europe rejects Pfizer arthritis drug

 April 27, 2013

Pfizer Inc. said Thursday that the European Union's committee of medical experts has rejected the company's drug Xeljanz for patients with rheumatoid arthritis.
The European Medicines Agency committee...

Amarin gets renewed drug application

 April 24, 2013

Amarin Corp. plc, the Irish drug company with research headquarters in Groton, announced Tuesday that U.S. regulators have agreed to review its fish-oil medication Vascepa for an expanded group of patients not covered by similar prescription...

Amarin ‘blockbuster’ rated as just a bust

 April 12, 2013

Amarin Corp. plc, with research headquarters in Groton, has been cited as having one of the five most disappointing new drugs of the past half-decade.

The publication EvaluatePharma culled through drugs that were expected to be blockbusters...

Pfizer loses appeal in marketing fraud case

 April 12, 2013

Pfizer Inc. lost a federal appeals court ruling in Massachusetts Wednesday that will require it to pay the Kaiser Foundation Health Plan $142 million.

Kaiser had claimed damages based on the costs it incurred for health-plan beneficiaries...

Pfizer cancer drug gets thumbs up

 April 11, 2013

An experimental mid-stage breast cancer drug developed by Pfizer Inc. has won breakthrough status from federal regulators.

Pfizer reported Wednesday that the U.S. Food and Drug Administration had received positive feedback about the drug...

Pfizer partners with nanotechnology firm

 April 4, 2013

Pfizer Inc. said Wednesday that a new collaboration with Massachusetts-based BIND Therapeutics could eventually lead to drug work at company laboratories in Groton.

New York-based Pfizer confirmed a deal Wednesday that would pay BIND up to...

Pfizer says concerns about time frame, security contributed to demolition decision

 March 31, 2013

As Pfizer Inc. offered further explanations of its decision to raze a complex of buildings on its campus here, others were trying to understand why the pharmaceutical giant pulled out of an ongoing sales negotiation for what is known as Building 118.

Demolishing Pfizer complex a long, complicated process

 March 29, 2013

Carlton M. Smith, the zoning and building official for the City of Groton, said Pfizer has not yet applied for a demolition permit.

Pfizer stuns officials, will demolish Building 118

 March 27, 2013

“This decision by Pfizer is very disappointing," Mark Ojakian, the governor's chief of staff, said in a statement, “especially considering that the state was ready to provide substantial support to keep the building from being...

Pfizer's RA drug wins OK in Japan

 March 27, 2013

A drug brought to life by the Pfizer Inc. laboratories in Groton has earned approval from Japanese regulatory authorities.

Pfizer announced this week that the Japanese Ministry of Health, Labor and Welfare approved use of the rheumatoid...

Jackson Lab chief says state could benefit from scientific 'ecosystem'

 March 23, 2013

The head of The Jackson Laboratory says one way to make Connecticut a world-class bioscience center is to create a network of scientists, consultants, businesses, hospitals and insurance companies to attack specific problems.

StemCONN conference kicks off April 3

 March 22, 2013

Gov. Dannel P. Malloy will kick off the StemCONN 2013 Stem Cell Symposium Wednesday, April 3, at the Omni Hotel in New Haven.

The symposium is expected to bring together international experts in stem cell research.

Other speakers...

Columnists

Popular on theday.com

Interact